Effects of siRNA-mediated HIF-1α gene silencing on angiogenesis in osteosarcoma
Xu-dong Zhang, Qiang Wu, Shuhua Yang
Abstract
Open-access reader
Xu-dong Zhang, Qiang Wu, Shuhua Yang
Abstract
Open-access reader
Objective: To explore angiogenesis in osteosarcoma under the condition of hypoxia-inducible factor (HIF)-1? gene silenced by small interference RNA (siRNA).Methods: The SaOS-2 osteosarcoma cells, transfected with the recombinant plasmid pSilencer2.1-HIF-1? or pSilencer2.1-SCR, were classified as HIF-1?/siRNA group or SCR/siRNA group, respectively. In which, vascular endothelial growth factor (VEGF) immunohistochemistry were performed. HIF-1? and VEGF protein contents were detected by western blot. Gene expressions of HIF-1? and VEGF were quantified by qPCR. Then the transfected SaOS-2 cells were inoculated in nude mice and transplantation tumor were checked via HE staining, VEGF and CD34 immunohistochemistry, and calculation of microvascular density (MVD).Results: In vitro, VEGF immunohistochemistry stains, HIF-1? and VEGF protein contents, and the relative expressions of HIF-1? mRNA and VEGF mRNA in HIF-1?/siRNA group were obviously reduced. In vivo, morphological observation illustrated that heteromorphism were not obvious in the cells of HIF-1?/siRNA group and vascular systems were sparse in its transplantation tumor tissue, and immunohistochemistry revealed that both VEGF and CD34 stains were significantly decreased in HIF-1?/siRNA group, and MVD in HIF-1?/siRNA group (7.3
OpenAlex reports 14 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To explore angiogenesis in osteosarcoma under the condition of hypoxia-inducible factor (HIF)-1? gene silenced by small interference RNA (siRNA).Methods: The SaOS-2 osteosarcoma cells, transfected with the recombinant plasmid pSilencer2.1-HIF-1? or pSilencer2.1-SCR, were classified as HIF-1?/siRNA group or SCR/siRNA group, respectively. In which, vascular endothelial growth factor (VEGF) immunohistochemistry were performed. HIF-1? and VEGF protein contents were detected by western blot. Gene expressions of HIF-1? and VEGF were quantified by qPCR. Then the transfected SaOS-2 cells were inoculated in nude mice and transplantation tumor were checked via HE staining, VEGF and CD34 immunohistochemistry, and calculation of microvascular density (MVD).Results: In vitro, VEGF immunohistochemistry stains, HIF-1? and VEGF protein contents, and the relative expressions of HIF-1? mRNA and VEGF mRNA in HIF-1?/siRNA group were obviously reduced. In vivo, morphological observation illustrated that heteromorphism were not obvious in the cells of HIF-1?/siRNA group and vascular systems were sparse in its transplantation tumor tissue, and immunohistochemistry revealed that both VEGF and CD34 stains were significantly decreased in HIF-1?/siRNA group, and MVD in HIF-1?/siRNA group (7.3
Key concepts: Medicine, Gene silencing, Angiogenesis, Osteosarcoma, Cancer research, Small interfering RNA, Gene, Genetics